25 XP   0   0   10

Zhejiang Tianyu Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Tianyu Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Tianyu Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Tianyu Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Tianyu Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Tianyu Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Tianyu Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Tianyu Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥10.14
Expected worth in 1 year
¥9.67
How sure are you?
73.7%

+ What do you gain per year?

Total Gains per Share
¥-0.31
Return On Investment
-1.6%

For what price can you sell your share?

Current Price per Share
¥19.12
Expected price per share
¥15.48 - ¥23.29
How sure are you?
50%

1. Valuation of Zhejiang Tianyu Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥19.12

Intrinsic Value Per Share

¥-29.87 - ¥-35.14

Total Value Per Share

¥-19.73 - ¥-25.00

2. Growth of Zhejiang Tianyu Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Tianyu Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$487.3m$517.8m-$27.8m-5.7%

How much money is Zhejiang Tianyu Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3m$1.2m-$4.3m-142.1%
Net Profit Margin-4.9%0.8%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Tianyu Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Tianyu Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Tianyu Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Tianyu Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Tianyu Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Tianyu Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Tianyu Pharmaceutical Co Ltd is ¥19.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Tianyu Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Tianyu Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.14. Based on the TTM, the Book Value Change Per Share is ¥-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Tianyu Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%-0.010.0%0.000.0%0.030.2%0.030.2%
Usd Book Value Change Per Share-0.02-0.1%-0.02-0.1%-0.010.0%0.070.4%0.070.4%
Usd Dividend Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share-0.01-0.1%-0.01-0.1%0.000.0%0.080.4%0.080.4%
Usd Price Per Share3.06-3.30-5.04-4.94-4.94-
Price to Earnings Ratio2,826.27-691.74--705.36-20.64-20.64-
Price-to-Total Gains Ratio-298.97--173.29-66.71-28.04-28.04-
Price to Book Ratio2.19-2.34-3.39-4.29-4.29-
Price-to-Total Gains Ratio-298.97--173.29-66.71-28.04-28.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.640472
Number of shares378
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.020.07
Usd Total Gains Per Share-0.010.08
Gains per Quarter (378 shares)-4.0530.64
Gains per Year (378 shares)-16.22122.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
19-25-2611111113
217-50-4222223236
326-74-5833334359
434-99-7444446482
543-124-9056557605
652-149-10667669728
760-174-12278780851
869-199-13889892974
978-223-15410010031097
1086-248-17011111151220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%8.04.00.066.7%15.04.00.078.9%15.04.00.078.9%15.04.00.078.9%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%12.07.00.063.2%12.07.00.063.2%12.07.00.063.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%14.05.00.073.7%14.05.00.073.7%14.05.00.073.7%

Fundamentals of Zhejiang Tianyu Pharmaceutical Co Ltd

About Zhejiang Tianyu Pharmaceutical Co Ltd

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It provides fine chemicals and CDMO services. Zhejiang Tianyu Pharmaceutical Co., Ltd. was founded in 1993 and is based in Taizhou, China.

Fundamental data was last updated by Penke on 2024-04-23 07:58:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Tianyu Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Tianyu Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.1% means that ¥0.00 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.1%. The company is not making a profit/loss.
  • The TTM is -4.9%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-4.9%+5.1%
TTM-4.9%YOY0.8%-5.7%
TTM-4.9%5Y11.9%-16.8%
5Y11.9%10Y11.9%0.0%
1.1.2. Return on Assets

Shows how efficient Zhejiang Tianyu Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Assets means that Zhejiang Tianyu Pharmaceutical Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-0.3%+0.4%
TTM-0.3%YOY0.2%-0.5%
TTM-0.3%5Y2.3%-2.7%
5Y2.3%10Y2.3%0.0%
1.1.3. Return on Equity

Shows how efficient Zhejiang Tianyu Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Zhejiang Tianyu Pharmaceutical Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-0.7%+0.7%
TTM-0.7%YOY0.2%-0.9%
TTM-0.7%5Y3.3%-4.0%
5Y3.3%10Y3.3%0.0%

1.2. Operating Efficiency of Zhejiang Tianyu Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Tianyu Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Tianyu Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.8%-6.8%
TTM6.8%YOY1.4%+5.4%
TTM6.8%5Y16.0%-9.2%
5Y16.0%10Y16.0%0.0%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Tianyu Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.45 means that the operating costs are ¥1.45 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 1.451. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.548. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.451TTM1.548-0.097
TTM1.548YOY1.686-0.138
TTM1.5485Y1.407+0.141
5Y1.40710Y1.4070.000

1.3. Liquidity of Zhejiang Tianyu Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Tianyu Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.16 means the company has ¥1.16 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 1.156. The company is just able to pay all its short-term debts.
  • The TTM is 1.162. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.156TTM1.162-0.006
TTM1.162YOY1.393-0.231
TTM1.1625Y1.685-0.524
5Y1.68510Y1.6850.000
1.3.2. Quick Ratio

Measures if Zhejiang Tianyu Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.15 means the company can pay off ¥0.15 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.150. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.185. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.150TTM0.185-0.035
TTM0.185YOY0.247-0.062
TTM0.1855Y0.339-0.154
5Y0.33910Y0.3390.000

1.4. Solvency of Zhejiang Tianyu Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Tianyu Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.44 means that Zhejiang Tianyu Pharmaceutical Co Ltd assets are financed with 44.2% credit (debt) and the remaining percentage (100% - 44.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.442. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.444. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.442TTM0.444-0.001
TTM0.444YOY0.388+0.056
TTM0.4445Y0.348+0.096
5Y0.34810Y0.3480.000
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Tianyu Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 79.4% means that company has ¥0.79 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The MRQ is 0.794. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.799. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.794TTM0.799-0.005
TTM0.799YOY0.635+0.164
TTM0.7995Y0.551+0.247
5Y0.55110Y0.5510.000

2. Market Valuation of Zhejiang Tianyu Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Tianyu Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Tianyu Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 2,826.27 means the investor is paying ¥2,826.27 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The EOD is 2,435.255. Based on the earnings, the company is expensive. -2
  • The MRQ is 2,826.271. Based on the earnings, the company is expensive. -2
  • The TTM is 691.739. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2,435.255MRQ2,826.271-391.016
MRQ2,826.271TTM691.739+2,134.532
TTM691.739YOY-705.355+1,397.094
TTM691.7395Y20.644+671.095
5Y20.64410Y20.6440.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The EOD is -14.771. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.143. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -16.425. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.771MRQ-17.143+2.372
MRQ-17.143TTM-16.425-0.718
TTM-16.425YOY-8.545-7.880
TTM-16.4255Y140.333-156.758
5Y140.33310Y140.3330.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Tianyu Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Tianyu Pharmaceutical Co Ltd:

  • The EOD is 1.885. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.188. Based on the equity, the company is underpriced. +1
  • The TTM is 2.344. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.885MRQ2.188-0.303
MRQ2.188TTM2.344-0.156
TTM2.344YOY3.387-1.043
TTM2.3445Y4.285-1.941
5Y4.28510Y4.2850.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Tianyu Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.114-0.119+4%-0.039-66%0.534-121%0.534-121%
Book Value Per Share--10.14210.196-1%10.776-6%8.801+15%8.801+15%
Current Ratio--1.1561.1620%1.393-17%1.685-31%1.685-31%
Debt To Asset Ratio--0.4420.4440%0.388+14%0.348+27%0.348+27%
Debt To Equity Ratio--0.7940.799-1%0.635+25%0.551+44%0.551+44%
Dividend Per Share--0.0400.041-4%0.038+4%0.053-26%0.053-26%
Eps--0.002-0.064+3355%0.027-93%0.213-99%0.213-99%
Free Cash Flow Per Share---0.324-0.410+27%-0.373+15%-0.266-18%-0.266-18%
Free Cash Flow To Equity Per Share---0.324-0.048-85%-0.196-40%0.024-1467%0.024-1467%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---35.142--------
Intrinsic Value_10Y_min---29.870--------
Intrinsic Value_1Y_max---2.163--------
Intrinsic Value_1Y_min---2.124--------
Intrinsic Value_3Y_max---7.534--------
Intrinsic Value_3Y_min---7.171--------
Intrinsic Value_5Y_max---14.153--------
Intrinsic Value_5Y_min---13.047--------
Market Cap6653320087.040-16%7721613158.2108314914214.305-7%12710735675.373-39%12453996853.649-38%12453996853.649-38%
Net Profit Margin--0.001-0.049+3839%0.008-84%0.119-99%0.119-99%
Operating Margin---0.068-100%0.014-100%0.160-100%0.160-100%
Operating Ratio--1.4511.548-6%1.686-14%1.407+3%1.407+3%
Pb Ratio1.885-16%2.1882.344-7%3.387-35%4.285-49%4.285-49%
Pe Ratio2435.255-16%2826.271691.739+309%-705.355+125%20.644+13590%20.644+13590%
Price Per Share19.120-16%22.19023.895-7%36.528-39%35.790-38%35.790-38%
Price To Free Cash Flow Ratio-14.771+14%-17.143-16.425-4%-8.545-50%140.333-112%140.333-112%
Price To Total Gains Ratio-257.607+14%-298.969-173.293-42%66.708-548%28.040-1166%28.040-1166%
Quick Ratio--0.1500.185-19%0.247-39%0.339-56%0.339-56%
Return On Assets--0.000-0.003+3330%0.002-93%0.023-100%0.023-100%
Return On Equity--0.000-0.007+3470%0.002-92%0.033-99%0.033-99%
Total Gains Per Share---0.074-0.078+5%-0.001-99%0.587-113%0.587-113%
Usd Book Value--487372530.175489998553.640-1%517823678.084-6%422941189.569+15%422941189.569+15%
Usd Book Value Change Per Share---0.016-0.016+4%-0.005-66%0.074-121%0.074-121%
Usd Book Value Per Share--1.4011.408-1%1.488-6%1.215+15%1.215+15%
Usd Dividend Per Share--0.0050.006-4%0.005+4%0.007-26%0.007-26%
Usd Eps--0.000-0.009+3355%0.004-93%0.029-99%0.029-99%
Usd Free Cash Flow---15550861.293-19714480.309+27%-17902275.098+15%-12793855.884-18%-12793855.884-18%
Usd Free Cash Flow Per Share---0.045-0.057+27%-0.051+15%-0.037-18%-0.037-18%
Usd Free Cash Flow To Equity Per Share---0.045-0.007-85%-0.027-40%0.003-1467%0.003-1467%
Usd Market Cap918823504.020-16%1066354777.1491148289652.996-7%1755352596.769-39%1719896965.489-38%1719896965.489-38%
Usd Price Per Share2.640-16%3.0643.300-7%5.044-39%4.943-38%4.943-38%
Usd Profit--94325.236-3070036.250+3355%1291145.416-93%10227145.997-99%10227145.997-99%
Usd Revenue--71614559.81184491074.029-15%92857383.706-23%85583029.939-16%85583029.939-16%
Usd Total Gains Per Share---0.010-0.011+5%0.000-99%0.081-113%0.081-113%
 EOD+4 -4MRQTTM+19 -16YOY+9 -265Y+6 -2910Y+6 -29

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Tianyu Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152,435.255
Price to Book Ratio (EOD)Between0-11.885
Net Profit Margin (MRQ)Greater than00.001
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.150
Current Ratio (MRQ)Greater than11.156
Debt to Asset Ratio (MRQ)Less than10.442
Debt to Equity Ratio (MRQ)Less than10.794
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Tianyu Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.920
Ma 20Greater thanMa 5017.086
Ma 50Greater thanMa 10017.055
Ma 100Greater thanMa 20018.552
OpenGreater thanClose18.360
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  1,77310,89112,664-10,9461,7183,8695,587-14,181-8,594



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,329,655
Total Liabilities2,800,528
Total Stockholder Equity3,529,128
 As reported
Total Liabilities 2,800,528
Total Stockholder Equity+ 3,529,128
Total Assets = 6,329,655

Assets

Total Assets6,329,655
Total Current Assets2,967,690
Long-term Assets3,361,965
Total Current Assets
Cash And Cash Equivalents 434,053
Net Receivables 385,892
Inventory 1,961,059
Other Current Assets 25,914
Total Current Assets  (as reported)2,967,690
Total Current Assets  (calculated)2,806,917
+/- 160,773
Long-term Assets
Property Plant Equipment 2,783,286
Intangible Assets 424,588
Long-term Assets Other 37,893
Long-term Assets  (as reported)3,361,965
Long-term Assets  (calculated)3,245,766
+/- 116,199

Liabilities & Shareholders' Equity

Total Current Liabilities2,567,291
Long-term Liabilities233,237
Total Stockholder Equity3,529,128
Total Current Liabilities
Short Long Term Debt 1,555,171
Accounts payable 758,358
Other Current Liabilities 988
Total Current Liabilities  (as reported)2,567,291
Total Current Liabilities  (calculated)2,314,517
+/- 252,774
Long-term Liabilities
Long term Debt 138,173
Capital Lease Obligations Min Short Term Debt19,583
Long-term Liabilities Other 6,977
Long-term Liabilities  (as reported)233,237
Long-term Liabilities  (calculated)164,732
+/- 68,505
Total Stockholder Equity
Retained Earnings 1,675,479
Total Stockholder Equity (as reported)3,529,128
Total Stockholder Equity (calculated)1,675,479
+/- 1,853,649
Other
Capital Stock347,977
Common Stock Shares Outstanding 347,977
Net Debt 1,259,291
Net Invested Capital 5,222,471
Net Working Capital 400,399
Property Plant and Equipment Gross 2,783,286



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
2,578,114
2,676,081
2,747,873
2,840,228
3,010,298
3,230,368
3,486,532
4,889,568
4,956,694
5,074,863
5,558,414
5,800,602
6,120,893
6,302,770
6,294,410
6,415,750
6,428,673
6,348,669
6,329,655
6,329,6556,348,6696,428,6736,415,7506,294,4106,302,7706,120,8935,800,6025,558,4145,074,8634,956,6944,889,5683,486,5323,230,3683,010,2982,840,2282,747,8732,676,0812,578,114
   > Total Current Assets 
1,466,434
1,454,380
1,453,199
1,480,943
1,604,832
1,733,754
1,802,955
2,910,912
2,711,849
2,642,585
2,778,244
2,832,208
3,035,140
3,108,545
3,052,160
3,017,675
3,055,508
2,994,788
2,967,690
2,967,6902,994,7883,055,5083,017,6753,052,1603,108,5453,035,1402,832,2082,778,2442,642,5852,711,8492,910,9121,802,9551,733,7541,604,8321,480,9431,453,1991,454,3801,466,434
       Cash And Cash Equivalents 
352,686
197,933
245,956
142,096
271,501
322,036
341,161
1,296,236
986,745
685,302
721,586
476,753
622,221
671,377
511,866
476,981
554,452
447,034
434,053
434,053447,034554,452476,981511,866671,377622,221476,753721,586685,302986,7451,296,236341,161322,036271,501142,096245,956197,933352,686
       Short-term Investments 
0
0
0
0
0
0
15,892
37,910
10,873
14,118
15,111
72,944
25,987
0
0
0
6,803
0
0
006,80300025,98772,94415,11114,11810,87337,91015,892000000
       Net Receivables 
312,450
331,695
358,906
347,479
325,662
441,636
442,470
452,365
536,717
533,478
473,382
495,300
570,157
542,973
401,927
461,558
533,512
533,069
385,892
385,892533,069533,512461,558401,927542,973570,157495,300473,382533,478536,717452,365442,470441,636325,662347,479358,906331,695312,450
       Inventory 
604,590
671,642
716,077
871,966
803,483
860,482
905,281
994,844
1,045,795
1,245,171
1,400,174
1,598,501
1,636,424
1,788,631
1,999,200
2,017,183
1,878,525
1,947,922
1,961,059
1,961,0591,947,9221,878,5252,017,1831,999,2001,788,6311,636,4241,598,5011,400,1741,245,1711,045,795994,844905,281860,482803,483871,966716,077671,642604,590
       Other Current Assets 
123,219
174,234
44,811
112,425
204,186
109,600
98,151
129,557
131,718
164,515
167,991
188,709
180,352
104,083
139,168
61,952
82,214
66,763
25,914
25,91466,76382,21461,952139,168104,083180,352188,709167,991164,515131,718129,55798,151109,600204,186112,42544,811174,234123,219
   > Long-term Assets 
1,111,680
1,221,701
1,294,674
1,359,285
1,405,466
1,496,614
1,683,576
1,978,656
2,244,845
2,432,278
2,780,170
2,968,394
3,085,753
3,194,225
3,242,250
3,398,075
3,373,166
3,353,881
3,361,965
3,361,9653,353,8813,373,1663,398,0753,242,2503,194,2253,085,7532,968,3942,780,1702,432,2782,244,8451,978,6561,683,5761,496,6141,405,4661,359,2851,294,6741,221,7011,111,680
       Property Plant Equipment 
937,095
1,025,795
1,105,956
1,177,257
1,223,727
1,306,145
1,436,835
1,663,474
1,839,325
2,106,191
2,257,104
2,464,993
2,590,981
2,667,349
2,718,144
2,810,010
2,804,251
2,779,969
2,783,286
2,783,2862,779,9692,804,2512,810,0102,718,1442,667,3492,590,9812,464,9932,257,1042,106,1911,839,3251,663,4741,436,8351,306,1451,223,7271,177,2571,105,9561,025,795937,095
       Intangible Assets 
148,583
1,058
166,799
165,711
164,983
164,554
215,311
241,345
307,642
239,253
396,234
374,753
372,196
377,689
378,067
423,943
422,619
421,583
424,588
424,588421,583422,619423,943378,067377,689372,196374,753396,234239,253307,642241,345215,311164,554164,983165,711166,7991,058148,583
       Other Assets 
15,364
17,978
11,282
5,816
6,256
15,415
15,831
63,776
67,817
43,916
47,090
50,043
43,970
63,296
64,996
133,672
109,171
113,977
0
0113,977109,171133,67264,99663,29643,97050,04347,09043,91667,81763,77615,83115,4156,2565,81611,28217,97815,364
> Total Liabilities 
997,987
981,592
859,813
803,092
803,187
874,130
932,409
1,342,830
1,256,181
1,390,222
1,809,806
2,091,388
2,315,720
2,513,280
2,599,772
2,920,744
2,828,967
2,779,936
2,800,528
2,800,5282,779,9362,828,9672,920,7442,599,7722,513,2802,315,7202,091,3881,809,8061,390,2221,256,1811,342,830932,409874,130803,187803,092859,813981,592997,987
   > Total Current Liabilities 
936,579
921,658
791,802
737,301
738,914
826,616
881,231
1,229,720
1,143,518
1,275,423
1,645,990
1,877,447
2,105,684
2,314,878
2,388,360
2,670,028
2,584,861
2,541,628
2,567,291
2,567,2912,541,6282,584,8612,670,0282,388,3602,314,8782,105,6841,877,4471,645,9901,275,4231,143,5181,229,720881,231826,616738,914737,301791,802921,658936,579
       Short-term Debt 
381,000
318,630
170,000
42,348
132,106
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000132,10642,348170,000318,630381,000
       Short Long Term Debt 
381,000
318,630
170,000
42,348
132,106
101,502
100,768
202,195
246,194
271,905
577,559
422,964
607,783
653,870
913,904
1,066,355
1,383,517
1,387,547
1,555,171
1,555,1711,387,5471,383,5171,066,355913,904653,870607,783422,964577,559271,905246,194202,195100,768101,502132,10642,348170,000318,630381,000
       Accounts payable 
450,825
485,390
471,433
471,493
503,905
592,207
628,527
803,604
764,955
878,541
951,284
1,172,646
1,267,675
1,510,899
1,302,665
1,357,711
1,006,128
917,163
758,358
758,358917,1631,006,1281,357,7111,302,6651,510,8991,267,6751,172,646951,284878,541764,955803,604628,527592,207503,905471,493471,433485,390450,825
       Other Current Liabilities 
10,169
11,546
11,546
123,270
70,726
66,087
83,921
88,145
82,385
45,563
35,291
50,497
73,003
47,129
88,719
76,718
65,089
123,645
988
988123,64565,08976,71888,71947,12973,00350,49735,29145,56382,38588,14583,92166,08770,726123,27011,54611,54610,169
   > Long-term Liabilities 
61,408
59,934
68,011
65,791
64,273
47,514
51,179
113,110
112,663
114,799
163,817
213,942
210,037
198,401
211,412
250,716
244,106
238,308
233,237
233,237238,308244,106250,716211,412198,401210,037213,942163,817114,799112,663113,11051,17947,51464,27365,79168,01159,93461,408
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
23,854
24,180
23,724
23,355
21,869
18,648
17,946
19,583
19,58317,94618,64821,86923,35523,72424,18023,85400000000000
       Other Liabilities 
61,408
59,934
68,011
65,791
64,273
47,514
51,179
65,051
64,604
67,747
64,177
92,970
88,776
80,677
95,057
85,649
81,539
76,679
0
076,67981,53985,64995,05780,67788,77692,97064,17767,74764,60465,05151,17947,51464,27365,79168,01159,93461,408
> Total Stockholder Equity
1,580,127
1,694,490
1,888,060
2,037,136
2,207,111
2,356,238
2,554,122
3,546,738
3,700,513
3,684,641
3,748,607
3,709,213
3,805,172
3,789,490
3,694,638
3,495,006
3,599,706
3,568,733
3,529,128
3,529,1283,568,7333,599,7063,495,0063,694,6383,789,4903,805,1723,709,2133,748,6073,684,6413,700,5133,546,7382,554,1222,356,2382,207,1112,037,1361,888,0601,694,4901,580,127
   Common Stock
182,239
182,239
182,239
182,224
182,224
182,224
182,224
182,224
193,324
347,977
347,977
347,977
347,977
347,977
347,977
347,977
347,977
347,977
0
0347,977347,977347,977347,977347,977347,977347,977347,977347,977193,324182,224182,224182,224182,224182,224182,239182,239182,239
   Retained Earnings 
678,130
776,698
966,963
1,177,095
1,343,587
1,467,269
1,663,906
1,760,637
1,894,098
1,844,600
1,870,023
1,868,655
1,953,376
1,928,807
1,872,622
1,714,905
1,815,143
1,783,017
1,675,479
1,675,4791,783,0171,815,1431,714,9051,872,6221,928,8071,953,3761,868,6551,870,0231,844,6001,894,0981,760,6371,663,9061,467,2691,343,5871,177,095966,963776,698678,130
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
0
-137
-137
-137
-137
893,921
-137
-137
-137
-137
-137
-137
-137
-137
-137
-137
0
0-137-137-137-137-137-137-137-137-137-137893,921-137-137-137-137000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,447,243
Cost of Revenue-1,567,455
Gross Profit-879,788
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development245,715
Selling General Administrative137,422
Selling And Marketing Expenses-
Operating Expense-383,137
 
Net Interest Income (+$)
Interest Income7,939
Interest Expense-45,750
Other Finance Cost-37,811
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = -45,750
-88,922
-43,172
Interest Expense45,750
Earnings Before Interest and Taxes (EBIT)-45,750
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-88,922
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Zhejiang Tianyu Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Tianyu Pharmaceutical Co Ltd. The general trend of Zhejiang Tianyu Pharmaceutical Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Tianyu Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Tianyu Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 19.83 < 20.02 < 23.29.

The bearish price targets are: 18.49 > 16.02 > 15.48.

Tweet this
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Tianyu Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Tianyu Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current macd is 0.43293786.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Tianyu Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Tianyu Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Tianyu Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current adx is 21.36.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Tianyu Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Tianyu Pharmaceutical Co Ltd. The current sar is 16.76.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current rsi is 67.92. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Tianyu Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Tianyu Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current cci is 185.83.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current cmo is 49.29.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Tianyu Pharmaceutical Co Ltd. The current willr is -17.98941799.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Tianyu Pharmaceutical Co Ltd.

Zhejiang Tianyu Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current atr is 0.75219567.

Zhejiang Tianyu Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current obv is -66,434,494.

Zhejiang Tianyu Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Tianyu Pharmaceutical Co Ltd. The current mfi is 67.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Tianyu Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Tianyu Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Tianyu Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Zhejiang Tianyu Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Tianyu Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.920
Ma 20Greater thanMa 5017.086
Ma 50Greater thanMa 10017.055
Ma 100Greater thanMa 20018.552
OpenGreater thanClose18.360
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Tianyu Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Tianyu Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Tianyu Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Tianyu Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Tianyu Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Tianyu Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Tianyu Pharmaceutical Co Ltd in your mailbox!